This Trend Will Only Proliferate as 2022 Progresses…
Kellen Finney, Eighth Revolution
Welcome to 2022, year four of legal CBD and rapidly approaching almost a decade of adult-use THC cannabis in Colorado and Washington. The cannabinoid industry is still in its infancy, with east coast states still sorting out sales of adult-use cannabis and CBD hanging out in limbo with respect to FDA’s lack of nutraceutical ruling. One industry that we believe could be poised for significant growth is the emerging minor cannabinoid market which seems to be blending the cannabis and hemp industries. The use of other cannabinoids such as CBG and CBN is becoming more popular in CPG products made with or without THC. We believe this trend will only proliferate as 2022 progresses and we look forward to being there with you a long way.
Removing the Stigma and Unlocking the Benefits will Take Time
Bryan Fields, Eighth Revolution
We as an industry are figuring everything out on the fly. Doctors are not educated about the ECS system. Politicians don’t understand the complex nuances of the industry and we as consumers barely understand the types of products we are selecting when walking into a dispensary. We must be patient and understand that removing the stigma and unlocking the potential extensive benefits of the plants will take time. We are still very early in the process, and the industry requires pioneers, innovators, and strong leaders to move the needle.
Editors’ Note: This is an excerpt from our Monthly Playbook. If you would like to read the full monthly playbook and join the thousands of others you can sign up below.
